Athira Pharma Inc

Company Profile

Athira Pharma Inc had its IPO on 2020-09-18 under the ticker symbol ATHA.

The company operates in the Healthcare sector and Biotechnology industry. Athira Pharma Inc has a staff strength of 63 employees.

Stock update

Shares of Athira Pharma Inc opened at $2.11 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.06 - $2.13, and closed at $2.06.

This is a -3.29% slip from the previous day's closing price.

A total volume of 55,347 shares were traded at the close of the day’s session.

In the last one week, shares of Athira Pharma Inc have slipped by -9.25%.

Athira Pharma Inc's Key Ratios

Athira Pharma Inc has a market cap of $114.23 million, indicating a price to book ratio of 0.4731 and a price to sales ratio of 0.

In the last 12-months Athira Pharma Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-99472000. The EBITDA ratio measures Athira Pharma Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Athira Pharma Inc’s operating margin was 0% while its return on assets stood at -23% with a return of equity of -39.95%.

In Q1, Athira Pharma Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Athira Pharma Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-3.02 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Athira Pharma Inc’s profitability.

Athira Pharma Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 1.1498. Its price to sales ratio in the trailing 12-months stood at 0.

Athira Pharma Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$232.77 million

Total Liabilities

$20.15 million

Operating Cash Flow

$35.52 million

Capital Expenditure

$241000

Dividend Payout Ratio

0%

Athira Pharma Inc ended 2024 with $232.77 million in total assets and $0 in total liabilities. Its intangible assets were valued at $232.77 million while shareholder equity stood at $211.13 million.

Athira Pharma Inc ended 2024 with $0 in deferred long-term liabilities, $20.15 million in other current liabilities, 4000.00 in common stock, $-219354000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $105.18 million and cash and short-term investments were $185.98 million. The company’s total short-term debt was $337,000 while long-term debt stood at $0.

Athira Pharma Inc’s total current assets stands at $192.90 million while long-term investments were $33.90 million and short-term investments were $80.80 million. Its net receivables were $0 compared to accounts payable of $892000.00 and inventory worth $0.

In 2024, Athira Pharma Inc's operating cash flow was $35.52 million while its capital expenditure stood at $241000.

Comparatively, Athira Pharma Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$2.06

52-Week High

$9.431

52-Week Low

$2.22

Analyst Target Price

$7.5

Athira Pharma Inc stock is currently trading at $2.06 per share. It touched a 52-week high of $9.431 and a 52-week low of $9.431. Analysts tracking the stock have a 12-month average target price of $7.5.

Its 50-day moving average was $2.71 and 200-day moving average was $2.96 The short ratio stood at 12.76 indicating a short percent outstanding of 0%.

Around 179.4% of the company’s stock are held by insiders while 7522% are held by institutions.